We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » MHRA Criticizes EU Drug Verification Plan as Costly
MHRA Criticizes EU Drug Verification Plan as Costly
May 10, 2012
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is taking issue with an EU plan to scan all drugs at the point of dispensing, saying the cost of providing scanners at all healthcare outlets is too burdensome.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor